Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Cash from Operations (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Cash from Operations for 17 consecutive years, with 1974000000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 55.53% to 1974000000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 14156000000.0 through Dec 2025, down 6.81% year-over-year, with the annual reading at 14156000000.0 for FY2025, 6.81% down from the prior year.
  • Cash from Operations for Q4 2025 was 1974000000.0 at Bristol Myers Squibb, down from 6311000000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 6311000000.0 in Q3 2025, with the low at 1887000000.0 in Q2 2023.
  • Average Cash from Operations over 5 years is 3623950000.0, with a median of 3749500000.0 recorded in 2022.
  • The sharpest move saw Cash from Operations surged 132.29% in 2021, then plummeted 55.53% in 2025.
  • Over 5 years, Cash from Operations stood at 4057000000.0 in 2021, then decreased by 18.51% to 3306000000.0 in 2022, then increased by 28.61% to 4252000000.0 in 2023, then rose by 4.4% to 4439000000.0 in 2024, then tumbled by 55.53% to 1974000000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 1974000000.0, 6311000000.0, and 3917000000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.